Ascendis Pharma A/S (ASND) Institutional Ownership

$205.81 -4.64 (-2.20%)

Closing price 04:00 PM Eastern

Extended Trading

$200.71 -5.10 (-2.48%)

As of 07:55 PM Eastern

Compare

Number of Institutional Buyers (last 12 months): 190
Total Institutional Inflows (last 12 months): $1.77B

Number of Institutional Sellers (last 12 months): 115
Total Institutional Outflows (last 12 months): $1.56B

Get ASND Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ascendis Pharma A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASND Institutional Buying and Selling by Quarter

Ascendis Pharma A/S Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/4/2026	Seven Fleet Capital Management LP	12,179	$2.79M	0.9%	+114.8%	0.020%
6/3/2026	Parallel Advisors LLC	304	$70K	0.0%	+94.9%	0.000%
5/29/2026	Perceptive Advisors LLC	1,531,421	$350.28M	6.8%	+41.6%	2.455%
5/19/2026	Tri Locum Partners LP	255,332	$58.40M	8.2%	-3.7%	0.409%
5/18/2026	Spyglass Capital Management LLC	367,972	$84.17M	6.0%	-11.4%	0.590%
5/18/2026	ADAR1 Capital Management LLC	25,014	$5.72M	0.3%	-1.2%	0.040%
5/18/2026	EverSource Wealth Advisors LLC	272	$62K	0.0%	+34.0%	0.000%
5/18/2026	Rock Springs Capital Management LP	194,000	$44.37M	2.6%	-4.7%	0.311%
5/18/2026	Eagle Health Investments LP	86,650	$19.82M	3.5%	N/A	0.139%
5/18/2026	Empowered Funds LLC	51,135	$11.70M	0.1%	+39.3%	0.082%
Get the Latest News and Ratings for ASND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.
5/16/2026	The Manufacturers Life Insurance Company	58,859	$13.46M	0.0%	-3.3%	0.094%
5/16/2026	Quantinno Capital Management LP	903	$207K	0.0%	N/A	0.001%
5/16/2026	Castleark Management LLC	67,616	$15.47M	0.5%	+1.9%	0.108%
5/16/2026	Orbimed Advisors LLC	181,977	$41.62M	0.8%	+5.8%	0.292%
5/15/2026	Troluce Capital Advisors LLC	99,600	$22.78M	1.4%	N/A	0.160%
5/15/2026	Rice Hall James & Associates LLC	148,386	$33.94M	1.9%	+2.3%	0.238%
5/15/2026	Affinity Asset Advisors LLC	95,000	$21.73M	1.1%	+216.7%	0.152%
5/14/2026	Renaissance Technologies LLC	117,332	$26.84M	0.0%	N/A	0.188%
5/14/2026	Arrowstreet Capital Limited Partnership	91,470	$20.92M	0.0%	N/A	0.147%
5/14/2026	Atika Capital Management LLC	19,125	$4.37M	0.5%	-7.3%	0.031%
5/14/2026	Sei Investments Co.	351,146	$80.32M	0.1%	+24.8%	0.563%
5/14/2026	State of Wyoming	1,210	$277K	0.0%	+47.6%	0.002%
5/13/2026	Cetera Investment Advisers	4,987	$1.14M	0.0%	+9.7%	0.008%
5/13/2026	First Trust Advisors LP	31,135	$7.12M	0.0%	+154.6%	0.050%
5/12/2026	Quantedge Capital Pte Ltd	11,000	$2.52M	1.4%	+19.6%	0.018%
5/12/2026	Barometer Capital Management Inc.	4,170	$954K	0.4%	-95.4%	0.007%
5/8/2026	PNC Financial Services Group Inc.	6,873	$1.57M	0.0%	-21.0%	0.011%
5/7/2026	Parallel Advisors LLC	304	$70K	0.0%	+94.9%	0.000%
5/7/2026	AlphaCentric Advisors LLC	4,526	$1.04M	1.0%	+39.8%	0.007%
5/7/2026	SEB Asset Management AB	38,665	$8.84M	0.0%	N/A	0.062%
5/6/2026	Dorsey Wright & Associates	11,879	$2.72M	0.3%	+39.7%	0.019%
5/6/2026	Assetmark Inc.	9,635	$2.20M	0.0%	+12.3%	0.015%
5/6/2026	Financiere des Professionnels Fonds d investissement inc.	4,276	$978K	0.1%	N/A	0.007%
5/6/2026	Allspring Global Investments Holdings LLC	184,224	$42.05M	0.1%	-1.8%	0.295%
5/5/2026	Marks Group Wealth Management Inc	3,938	$901K	0.1%	N/A	0.006%
5/5/2026	Bank of New York Mellon Corp	228,675	$52.31M	0.0%	-42.0%	0.367%
5/5/2026	Sigma Planning Corp	7,297	$1.67M	0.0%	+52.5%	0.012%
5/4/2026	Calamos Advisors LLC	15,390	$3.52M	0.0%	-5.6%	0.025%
5/4/2026	Principal Financial Group Inc.	896,397	$205.03M	0.1%	-12.7%	1.437%
5/4/2026	Chicago Partners Investment Group LLC	3,054	$706K	0.0%	-12.7%	0.005%
Trump’s New Dollar revealed (Ad) The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway. Read Porter Stansberry's full briefing and find out which moves to make now
5/2/2026	Diversify Wealth Management LLC	10,675	$2.35M	0.0%	+37.7%	0.017%
5/1/2026	Ferguson Wellman Capital Management Inc.	2,600	$595K	0.0%	N/A	0.004%
5/1/2026	Candriam S.C.A.	230,278	$52.67M	0.3%	+23.2%	0.369%
4/30/2026	Personal CFO Solutions LLC	1,519	$347K	0.0%	+4.4%	0.002%
4/27/2026	Leonteq Securities AG	855	$196K	0.0%	+405.9%	0.001%
4/27/2026	Fideuram Intesa Sanpaolo Private Banking S.P.A.	10,643	$2.43M	0.1%	-2.1%	0.017%
4/24/2026	Severin Investments LLC	2,195	$502K	0.4%	-2.3%	0.004%
4/22/2026	Pictet Asset Management Holding SA	251,833	$56.91M	0.1%	+243.0%	0.404%
4/22/2026	Braun Stacey Associates Inc.	130,992	$29.96M	1.0%	+10.0%	0.210%
4/22/2026	Sterling Capital Management LLC	14,929	$3.42M	0.1%	-39.8%	0.024%
4/20/2026	Blue Trust Inc.	170	$39K	0.0%	-48.0%	0.000%
4/16/2026	ARS Investment Partners LLC	209,456	$47.91M	2.5%	+20.0%	0.336%
4/16/2026	Diversified Trust Co	37,161	$8.50M	0.2%	-12.0%	0.060%
3/9/2026	Corient Private Wealth LLC	3,393	$724K	0.0%	+17.7%	0.005%
3/3/2026	Caitong International Asset Management Co. Ltd	195	$42K	0.0%	N/A	0.000%
2/26/2026	Seven Fleet Capital Management LP	5,670	$1.21M	0.9%	N/A	0.009%
2/20/2026	Dorsey Wright & Associates	8,504	$1.81M	0.4%	+3.2%	0.014%
2/19/2026	T. Rowe Price Investment Management Inc.	1,667,625	$355.61M	0.2%	-37.5%	2.691%
2/19/2026	Corient Private Wealth LLC	3,393	$724K	0.0%	+17.7%	0.005%
2/18/2026	Vident Advisory LLC	1,926	$411K	0.0%	-4.8%	0.003%
2/18/2026	Empowered Funds LLC	36,697	$7.83M	0.1%	+1.7%	0.059%
2/18/2026	XTX Topco Ltd	4,459	$951K	0.0%	N/A	0.007%
2/18/2026	Voloridge Investment Management LLC	216,173	$46.10M	0.2%	-7.8%	0.349%
2/18/2026	Vestal Point Capital LP	175,000	$37.32M	1.3%	-70.8%	0.282%
2/18/2026	Virtus Investment Advisers LLC	3,100	$661K	0.2%	+19.2%	0.005%
2/18/2026	Spyglass Capital Management LLC	415,549	$88.61M	4.4%	+6.9%	0.670%
2/18/2026	SummitTX Capital L.P.	970	$207K	0.0%	N/A	0.002%
2/18/2026	Sphera Funds Management LTD.	11,000	$2.35M	0.4%	N/A	0.018%
2/18/2026	Progeny 3 Inc.	5,230	$1.12M	0.1%	N/A	0.008%
2/18/2026	Orbimed Advisors LLC	171,977	$36.67M	0.8%	-10.4%	0.277%
2/18/2026	Perceptive Advisors LLC	1,081,421	$230.60M	4.1%	-0.7%	1.745%
2/18/2026	Moore Capital Management LP	125,000	$26.66M	0.4%	+38.9%	0.202%
2/18/2026	Ishara Investments LP	5,000	$1.07M	1.2%	N/A	0.008%
2/18/2026	Janus Henderson Group PLC	4,061,641	$866.10M	0.4%	-6.0%	6.553%
2/18/2026	Engineers Gate Manager LP	7,478	$1.60M	0.0%	-33.1%	0.012%
2/18/2026	Eversept Partners LP	48,241	$10.29M	0.5%	N/A	0.078%
2/18/2026	Catalio Capital Management LP	119,265	$25.43M	4.7%	-17.7%	0.192%
2/18/2026	Cormorant Asset Management LP	100,000	$21.32M	1.0%	N/A	0.161%
2/18/2026	Artia Global Partners LP	17,740	$3.78M	0.5%	+44.9%	0.029%
2/18/2026	Balyasny Asset Management L.P.	24,079	$5.14M	0.0%	N/A	0.039%
2/17/2026	Guggenheim Capital LLC	6,734	$1.44M	0.0%	+26.9%	0.011%
2/17/2026	ADAR1 Capital Management LLC	25,314	$5.40M	0.4%	-30.4%	0.041%
2/17/2026	Schonfeld Strategic Advisors LLC	2,581	$550K	0.0%	-93.3%	0.004%
2/17/2026	Henry James International Management Inc.	13,456	$2.87M	0.9%	-15.7%	0.022%
2/17/2026	Cetera Investment Advisers	4,548	$970K	0.0%	+18.9%	0.007%
2/17/2026	Jain Global LLC	216,526	$46.17M	0.2%	+502.1%	0.349%
2/17/2026	Quantedge Capital Pte Ltd	9,200	$1.96M	0.9%	+29.6%	0.015%
2/17/2026	Trexquant Investment LP	59,025	$12.59M	0.1%	+114.0%	0.095%
2/17/2026	FIL Ltd	478,641	$102.07M	0.1%	+4.2%	0.772%
2/17/2026	Jump Financial LLC	27,600	$5.89M	0.1%	+106.9%	0.045%
Goldman Sachs just told you what to buy (most people missed it) (Ad) Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free. See the stock positioned to solve AI's biggest power crisis
2/17/2026	Price T Rowe Associates Inc. MD	1,570,260	$334.84M	0.0%	-9.0%	2.533%
2/17/2026	T. Rowe Price Investment Management Inc.	1,080,224	$230.35M	0.2%	-59.5%	1.743%
2/17/2026	Rock Springs Capital Management LP	203,500	$43.39M	2.2%	-5.1%	0.328%
2/17/2026	Ninepoint Partners LP	2,115	$451K	0.1%	+182.4%	0.003%
2/17/2026	Osaic Holdings Inc.	1,140	$243K	0.0%	-13.6%	0.002%
2/17/2026	Integral Health Asset Management LLC	90,000	$19.19M	0.9%	+50.0%	0.145%
2/17/2026	Public Employees Retirement System of Ohio	5,784	$1.23M	0.0%	-54.8%	0.009%
2/17/2026	Diadema Partners LP	6,840	$1.46M	0.3%	-75.2%	0.011%
2/17/2026	Russell Investments Group Ltd.	34,910	$7.44M	0.0%	-84.2%	0.056%
2/17/2026	Atom Investors LP	15,478	$3.30M	0.3%	+65.9%	0.025%

ASND Institutional Ownership - Frequently Asked Questions

During the previous two years, 301 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were RA Capital Management L.P. ($1.60B), Westfield Capital Management Co. LP ($1.11B), Avoro Capital Advisors LLC ($1.02B), Janus Henderson Group PLC ($866.10M), Artisan Partners Limited Partnership ($687.89M), Capital International Investors ($653.36M), and FMR LLC ($650.99M).Learn more on Ascendis Pharma A/S's institutional investors.

Of the 258 institutional investors that purchased Ascendis Pharma A/S's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($1.41M), T. Rowe Price Investment Management Inc. ($1.29M), Principal Financial Group Inc. ($998.29K), Wellington Management Group LLP ($880.84K), Capital International Investors ($770.87K), Vestal Point Capital LP ($719.86K), and RA Capital Management L.P. ($571.07K).

Institutional investors have bought a total of 8,811,310 shares in the last 24 months. This purchase volume represents approximately $1.77B in transactions.

Of the 115 institutional investors that sold Ascendis Pharma A/S's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($2.59M), Artisan Partners Limited Partnership ($1.03M), Vestal Point Capital LP ($425K), Westfield Capital Management Co. LP ($293.56K), Janus Henderson Group PLC ($261.42K), Woodline Partners LP ($202.99K), and KBC Group NV ($200.06K).

Institutional investors have sold a total of 7,604,759 shares in the last 24 months. This volume of shares sold represents approximately $1.56B in transactions.

Related Companies

This page (NASDAQ:ASND) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ascendis Pharma A/S (ASND) Institutional Ownership

ASND Institutional Buying and Selling by Quarter

Ascendis Pharma A/S Major Shareholders & Ownership History

ASND Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ascendis Pharma A/S (ASND) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Ascendis Pharma A/S (NASDAQ:ASND)

ASND Institutional Buying and Selling by Quarter

Ascendis Pharma A/S Major Shareholders & Ownership History

ASND Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ASND shares?

Which institutional investors have been buying Ascendis Pharma A/S's stock?

How much institutional buying is happening at Ascendis Pharma A/S?

Which of Ascendis Pharma A/S's major shareholders have been selling company stock?

How much institutional selling is happening at Ascendis Pharma A/S?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools